0001104659-20-140312.txt : 20201229 0001104659-20-140312.hdr.sgml : 20201229 20201229215334 ACCESSION NUMBER: 0001104659-20-140312 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20201222 FILED AS OF DATE: 20201229 DATE AS OF CHANGE: 20201229 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: BERMAN DENNIS N CENTRAL INDEX KEY: 0001273858 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-39676 FILM NUMBER: 201423921 MAIL ADDRESS: STREET 1: 9605 SCRANTON RD STREET 2: STE 240 CITY: SAN DIEGO STATE: CA ZIP: 92121 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Inhibikase Therapeutics, Inc. CENTRAL INDEX KEY: 0001750149 STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] IRS NUMBER: 000000000 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 3350 RIVERWOOD PARKWAY SE, SUITE 1900 CITY: ATLANTA STATE: GA ZIP: 30339 BUSINESS PHONE: 678-392-3419 MAIL ADDRESS: STREET 1: 3350 RIVERWOOD PARKWAY SE, SUITE 1900 CITY: ATLANTA STATE: GA ZIP: 30339 4 1 tm2039455d6_form4.xml FORM 4 X0306 4 2020-12-22 0 0001750149 Inhibikase Therapeutics, Inc. IKT 0001273858 BERMAN DENNIS N 3350 RIVERWOOD PARKWAY SE, SUITE 1900 ATLANTA GA 30339 1 0 0 0 Stock Option (right to buy) 10.00 2020-12-22 4 A 0 6825 0 A 2021-12-22 2030-12-22 Common Stock 6825 6825 D /s/ Milton H. Werner, attorney-in-fact 2020-12-29